Early experience of COVID‐19 vaccine‐related adverse events among adolescents and young adults with rheumatic diseases: A single‐center study

Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

(2021) Anja Strangfeld et al.   ANNALS OF THE RHEUMATIC DISEASES

Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort

(2021) Ulf M Geisen et al.   ANNALS OF THE RHEUMATIC DISEASES

Risk of Severe COVID-19 Infection in Patients With Inflammatory Rheumatic Diseases

(2021) Javier Bachiller-Corral et al.   JOURNAL OF RHEUMATOLOGY

Canadian Rheumatology Association recommendation for the use of COVID-19 vaccination for patients with autoimmune rheumatic diseases

(2021) Glen S. Hazlewood et al.   JOURNAL OF RHEUMATOLOGY

Impact of disease-modifying antirheumatic drugs on vaccine immunogenicity in patients with inflammatory rheumatic and musculoskeletal diseases

(2021) Marcia A Friedman et al.   ANNALS OF THE RHEUMATIC DISEASES

LB0002 COVID-19 VACCINE SAFETY IN PATIENTS WITH RHEUMATIC AND MUSCULOSKELETAL DISEASE

(2021) P. M. Machado et al.   ANNALS OF THE RHEUMATIC DISEASES

Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study

(2021) Victoria Furer et al.   ANNALS OF THE RHEUMATIC DISEASES

Clinical features and outcomes of 76 patients with COVID-19-related multi-system inflammatory syndrome in children

(2021) Fatih Haslak et al.   CLINICAL RHEUMATOLOGY

Thromboembolic events in younger women exposed to Pfizer-BioNTech or Moderna COVID-19 vaccines

(2021) Maurizio Sessa et al.   Expert Opinion On Drug Safety

Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey

(2021) Mine Durusu Tanriover et al.   LANCET

Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial

(2021) Ana C. Medeiros-Ribeiro et al.   NATURE MEDICINE

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months

(2021) Stephen J. Thomas et al.   NEW ENGLAND JOURNAL OF MEDICINE

Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis

(2021) Lars Erik Bartels et al.   RHEUMATOLOGY INTERNATIONAL

Evaluation of Immune Response and Disease Status in SLE Patients Following SARS‐CoV‐2 Vaccination

(2021) Peter M. Izmirly et al.   Arthritis & Rheumatology

American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 3

(2021) Jeffrey R. Curtis et al.   Arthritis & Rheumatology

Safety and tolerability of the COVID‐19 mRNA‐vaccine in adolescents with juvenile idiopathic arthritis on treatment with TNF‐inhibitors

(2021) Dimitra Dimopoulou et al.   Arthritis & Rheumatology

Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey

(2021) Sebastian Eduardo Sattui et al.   RMD Open

Inactivated vaccines may not provide adequate protection in immunosuppressed patients with rheumatic diseases

(2021) Padmanabha Shenoy et al.   ANNALS OF THE RHEUMATIC DISEASES

Sudden sensorineural hearing loss after COVID-19 vaccination

(2021) Junhui Jeong et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Adverse events of six COVID-19 vaccines in patients with autoimmune rheumatic diseases: a cross-sectional study

(2021) Jorge Antonio Esquivel-Valerio et al.   RHEUMATOLOGY INTERNATIONAL

Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies

(2020) Sara Monti et al.   ANNALS OF THE RHEUMATIC DISEASES

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

(2020) Alba Grifoni et al.   CELL

COVID-19, chronic inflammatory rheumatic disease and anti-rheumatic treatments

(2020) Dieu-Donné Ouédraogo et al.   CLINICAL RHEUMATOLOGY

SARS-CoV-2 Infection in Children

(2020) Xiaoxia Lu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Management of childhood-onset autoinflammatory diseases during the COVID-19 pandemic

(2020) Fatih Haslak et al.   RHEUMATOLOGY INTERNATIONAL

Incidence and severeness of COVID-19 hospitalisation in patients with inflammatory rheumatic disease: a nationwide cohort study from Denmark

(2020) René Cordtz et al.   RHEUMATOLOGY